Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

Uni Centric Study, Phase III, for Safety Oral Mucosa Evaluation: Basic Acceptability With Odontological Follow up - Cepacol Canela Power

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00687037

Enrollment

Registered

2008-05-30

Start date

2008-01-31

Completion date

Unknown

Last updated

2009-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

oral hygiene

Brief summary

To prove the safety, in normal conditions, of the odontological use formulation of the product Cepacol Canela Power.

Interventions

DRUGCetylpyridinium chloride

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Integral buccal mucous (without oral pathologies); * Normal odontological exams;

Exclusion criteria

* Lactation or gestational risk or gestation; * Use of Anti-inflammatory or immunosuppression drugs 15 days before the study; * Being in odontological treatment; * Pathological or mucous disease which can interfere or active gynaecological disease which may interfere wtih study results; * Personal history of allergic disease in the area to be treated; * Allergic or atopic history;

Design outcomes

Primary

Measure	Time frame
Patients will be evaluated according to the adverse reactions and the intensity of them. The volunteers will also answer a questionnaire about the physical attributes of the product.	21 days

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026